Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
09/08/2023
Phan DB, Jourdain H, González-Quesada A, Zureik M, Rivera-Díaz R, Sahuquillo-Torralba A, Descalzo-Gallego MA, Lunt M, Garcia-Doval I, Sbidian E, Warren RB, Yiu ZZN.
Descargar documento
BMJ Open. 2023 Jul 14;13(7):e075197